About the Vulvar Cancer Session
Vulvar cancer, though relatively rare, can profoundly impact women's health. Research into this form of cancer focuses on early detection methods, personalized treatment options, and improving quality of life for patients. Scientists explore the role of HPV infection, smoking, and other risk factors in the development of vulvar cancer. Novel therapeutic approaches, including immunotherapy and targeted therapies, are being investigated to enhance treatment efficacy and reduce side effects. Additionally, efforts are underway to raise awareness about symptoms, promote regular screenings, and destigmatize discussions surrounding vulvar health. Collaborative efforts between researchers, healthcare providers, and advocacy groups are essential to advance our understanding of vulvar cancer and improve outcomes for those affected.
Topics Covered in Vulvar Cancer
HPV-Associated Disease
Lichen Sclerosus
Radical Local Excision
Sentinel Node Biopsy
Chemoradiation
Body Image & Sexuality
Related Scientific Sessions at CIOC 2027
Why Attend the Vulvar Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Vulvar Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Vulvar Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Vulvar Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Vulvar Cancer Conference 2027 — FAQs
What is the Vulvar Cancer track at CIOC 2027?
The Vulvar Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Vulvar Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Vulvar Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Vulvar Cancer are all welcome — whether presenting or attending.
Can I present my research in the Vulvar Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Vulvar Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Vulvar Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.